268 related articles for article (PubMed ID: 24938563)
1. Association between tumor necrosis factor-α antagonists and risk of cancer in patients with inflammatory bowel disease.
Nyboe Andersen N; Pasternak B; Basit S; Andersson M; Svanström H; Caspersen S; Munkholm P; Hviid A; Jess T
JAMA; 2014 Jun; 311(23):2406-13. PubMed ID: 24938563
[TBL] [Abstract][Full Text] [Related]
2. Association between tumour necrosis factor-α inhibitors and risk of serious infections in people with inflammatory bowel disease: nationwide Danish cohort study.
Nyboe Andersen N; Pasternak B; Friis-Møller N; Andersson M; Jess T
BMJ; 2015 Jun; 350():h2809. PubMed ID: 26048617
[TBL] [Abstract][Full Text] [Related]
3. Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study.
Rungoe C; Basit S; Ranthe MF; Wohlfahrt J; Langholz E; Jess T
Gut; 2013 May; 62(5):689-94. PubMed ID: 22961677
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumour necrosis factor-α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer in Denmark: a nationwide, population-based cohort study.
Waljee AK; Higgins PDR; Jensen CB; Villumsen M; Cohen-Mekelburg SA; Wallace BI; Berinstein JA; Allin KH; Jess T
Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):276-284. PubMed ID: 31836320
[TBL] [Abstract][Full Text] [Related]
5. Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease.
Lemaitre M; Kirchgesner J; Rudnichi A; Carrat F; Zureik M; Carbonnel F; Dray-Spira R
JAMA; 2017 Nov; 318(17):1679-1686. PubMed ID: 29114832
[TBL] [Abstract][Full Text] [Related]
6. Long-term Risk of Hospitalization for Somatic Diseases in Survivors of Adolescent or Young Adult Cancer.
Rugbjerg K; Olsen JH
JAMA Oncol; 2016 Feb; 2(2):193-200. PubMed ID: 26584448
[TBL] [Abstract][Full Text] [Related]
7. Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease.
Peter I; Dubinsky M; Bressman S; Park A; Lu C; Chen N; Wang A
JAMA Neurol; 2018 Aug; 75(8):939-946. PubMed ID: 29710331
[TBL] [Abstract][Full Text] [Related]
8. Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?
Askling J; van Vollenhoven RF; Granath F; Raaschou P; Fored CM; Baecklund E; Dackhammar C; Feltelius N; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Rantapää-Dahlqvist S; Saxne T; Klareskog L
Arthritis Rheum; 2009 Nov; 60(11):3180-9. PubMed ID: 19877027
[TBL] [Abstract][Full Text] [Related]
9. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years.
Jess T; Simonsen J; Jørgensen KT; Pedersen BV; Nielsen NM; Frisch M
Gastroenterology; 2012 Aug; 143(2):375-81.e1; quiz e13-4. PubMed ID: 22522090
[TBL] [Abstract][Full Text] [Related]
10. Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies.
Beigel F; Steinborn A; Schnitzler F; Tillack C; Breiteneicher S; John JM; Van Steen K; Laubender RP; Göke B; Seiderer J; Brand S; Ochsenkühn T
Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):735-44. PubMed ID: 24788825
[TBL] [Abstract][Full Text] [Related]
11. Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease.
Herrinton LJ; Liu L; Weng X; Lewis JD; Hutfless S; Allison JE
Am J Gastroenterol; 2011 Dec; 106(12):2146-53. PubMed ID: 22031357
[TBL] [Abstract][Full Text] [Related]
12. Use of azathioprine and the risk of cancer in inflammatory bowel disease.
Pasternak B; Svanström H; Schmiegelow K; Jess T; Hviid A
Am J Epidemiol; 2013 Jun; 177(11):1296-305. PubMed ID: 23514635
[TBL] [Abstract][Full Text] [Related]
13. Cancer in patients with rheumatic diseases exposed to TNF antagonists.
Carmona L; Abasolo L; Descalzo MA; Pérez-Zafrilla B; Sellas A; de Abajo F; Gomez-Reino JJ; ;
Semin Arthritis Rheum; 2011 Aug; 41(1):71-80. PubMed ID: 21093020
[TBL] [Abstract][Full Text] [Related]
14. Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with ulcerative colitis - a nationwide cohort study.
Nørgård BM; Nielsen J; Qvist N; Gradel KO; de Muckadell OB; Kjeldsen J
Aliment Pharmacol Ther; 2012 Jun; 35(11):1301-9. PubMed ID: 22506582
[TBL] [Abstract][Full Text] [Related]
15. Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with Crohn's disease--a nationwide cohort study.
Nørgård BM; Nielsen J; Qvist N; Gradel KO; de Muckadell OB; Kjeldsen J
Aliment Pharmacol Ther; 2013 Jan; 37(2):214-24. PubMed ID: 23190161
[TBL] [Abstract][Full Text] [Related]
16. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
17. Incidence of renal cell carcinoma in inflammatory bowel disease patients with and without anti-TNF treatment.
Wauters L; Billiet T; Papamichael K; Ballet V; Joniau S; Verschueren P; Silversmit G; Van Assche G; Vermeire S; Ferrante M
Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):84-90. PubMed ID: 27603297
[TBL] [Abstract][Full Text] [Related]
18. The Severity of Herpes Zoster in Inflammatory Bowel Disease Patients Treated With Anti-TNF Agents.
Khan N; Trivedi C; Shah Y; Patel D; Lewis J; Yang YX
Inflamm Bowel Dis; 2018 May; 24(6):1274-1279. PubMed ID: 29522099
[TBL] [Abstract][Full Text] [Related]
19. Time-dependent increased risk for serious infection from continuous use of tumor necrosis factor antagonists over three years in patients with rheumatoid arthritis.
Sakai R; Komano Y; Tanaka M; Nanki T; Koike R; Nagasawa H; Amano K; Nakajima A; Atsumi T; Koike T; Ihata A; Ishigatsubo Y; Saito K; Tanaka Y; Ito S; Sumida T; Tohma S; Tamura N; Fujii T; Sugihara T; Kawakami A; Hagino N; Ueki Y; Hashiramoto A; Nagasaka K; Miyasaka N; Harigai M;
Arthritis Care Res (Hoboken); 2012 Aug; 64(8):1125-34. PubMed ID: 22422487
[TBL] [Abstract][Full Text] [Related]
20. Endocrine Late Effects in Survivors of Cancer in Adolescence and Young Adulthood: A Danish Population-Based Cohort Study.
Jensen MV; Rugbjerg K; de Fine Licht S; Johansen C; Schmiegelow K; Andersen KK; Winther JF
JAMA Netw Open; 2018 Jun; 1(2):e180349. PubMed ID: 30646084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
